IFI-M · UBK Tri-Axis Balanced Series

Specimen SS-F-M3-02553 // MULTI-AXIS · IFI-M

UBK Tri-Axis Balanced Series I-PR

Solanum lycopersicum

Tomato

Tier IUBK Tri-Axis Balanced Series

Target Trait

1×

fold-change

Umami+Bitter-Attenuation+Kokumi balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-02553

Genomic Edits

5

GC Content

47.5%

Construct Length

3,944 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

mGluR1 + TAS2R38 (suppression) + CaSR

IFI Score

100

Pathway Edits

  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent UBK pathway operation
  • Cross-pathway regulatory circuit for balanced UBK triple-axis expression

Key Interventions

Triple-axis receptor co-activation: mGluR1, TAS2R38 (suppression), and CaSR pathways simultaneously engineeredBalanced tri-axis expression strategy (UBK) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I UBK triple-axis construct for advanced multi-modal sensory architecture combining umami, bitter-attenuation, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities